Knott David M Jr - POSEIDA THERAPEUTICS INC ownership

POSEIDA THERAPEUTICS INC's ticker is PSTX and the CUSIP is 73730P108. A total of 65 filers reported holding POSEIDA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Knott David M Jr ownership history of POSEIDA THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$248
-42.9%
140,9210.0%0.10%
-42.1%
Q1 2023$434
-51.5%
140,921
-16.5%
0.17%
-49.4%
Q4 2022$895
-99.8%
168,839
+11.6%
0.34%
+50.2%
Q3 2022$534,000
+301.5%
151,286
+673.2%
0.22%
+400.0%
Q4 2021$133,00019,5660.04%
Other shareholders
POSEIDA THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Aisling Capital Management LP 1,043,267$10,454,0001.67%
Boxer Capital, LLC 1,251,055$12,536,0000.44%
Pentwater Capital Management LP 4,967,227$49,772,0000.41%
KNOTT DAVID M 29,566$296,0000.10%
Perceptive Advisors 1,575,490$15,786,0000.10%
Virtus ETF Advisers LLC 24,287$243,0000.10%
Advisory Services Network, LLC 256,772$2,573,0000.08%
J. Goldman & Co LP 202,501$2,029,0000.08%
Ikarian Capital, LLC 85,837$861,0000.07%
Regent Investment Management LLC 25,000$251,0000.06%
View complete list of POSEIDA THERAPEUTICS INC shareholders